Mark W Perry - Net Worth and Insider Trading

Mark W Perry Net Worth

The estimated net worth of Mark W Perry is at least $715 Million dollars as of 2025-03-05. Mark W Perry is the 10% Owner of iShares Indl/Office Real Estate Capped and owns about 16,578,379 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $529 Million. Mark W Perry is the 10% Owner of Echo Global Logistics Inc and owns about 2,420,219 shares of Echo Global Logistics Inc (ECHO) stock worth over $117 Million. Mark W Perry is also the 10% Owner of Amicus Therapeutics Inc and owns about 5,650,340 shares of Amicus Therapeutics Inc (FOLD) stock worth over $51 Million. Besides these, Mark W Perry also holds InnerWorkings Inc (INWK) , Catalyst Biosciences Inc (CBIO) , Novation Companies Inc (NOVCQ) , TiVo Corp (TIVO) . Details can be seen in Mark W Perry's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark W Perry has not made any transactions after 2012-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Mark W Perry

Mark W Perry Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark W Perry owns 20 companies in total, including Workday Inc (WDAY) , Supernus Pharmaceuticals Inc (SUPN) , and InnerWorkings Inc (INWK) among others .

Click here to see the complete history of Mark W Perry’s form 4 insider trades.

Insider Ownership Summary of Mark W Perry

Ticker	Comapny	Transaction Date	Type of Owner
WDAY	Workday Inc	2012-10-11	10 percent owner
SUPN	Supernus Pharmaceuticals Inc	2012-04-30	10 percent owner
INWK	InnerWorkings Inc	2012-03-28	10 percent owner
		2012-03-07	10 percent owner
		2009-10-01	10 percent owner
		2011-11-03	10 percent owner
		2011-08-08	10 percent owner
		2011-05-03	10 percent owner
		2006-05-23	10 percent owner
		2011-03-10	10 percent owner
		2010-08-30	10 percent owner
		2010-06-30	10 percent owner
		2010-06-23	10 percent owner
		2009-05-08	10 percent owner
		2009-02-20	10 percent owner
		2006-05-09	10 percent owner
		2007-08-14	10 percent owner
		2006-04-12	10 percent owner
		2004-03-04	10 percent owner
		2009-04-03	10 percent owner

Mark W Perry Latest Holdings Summary

Mark W Perry currently owns a total of 7 stocks. Among these stocks, Mark W Perry owns 16,578,379 shares of iShares Indl/Office Real Estate Capped (FNIO) as of March 1, 2012, with a value of $529 Million and a weighting of 73.95%. Mark W Perry owns 2,420,219 shares of Echo Global Logistics Inc (ECHO) as of October 1, 2009, with a value of $117 Million and a weighting of 16.33%. Mark W Perry also owns 5,650,340 shares of Amicus Therapeutics Inc (FOLD) as of March 7, 2012, with a value of $51 Million and a weighting of 7.2%. The other 4 stocks InnerWorkings Inc (INWK) , Catalyst Biosciences Inc (CBIO) , Novation Companies Inc (NOVCQ) , TiVo Corp (TIVO) have a combined weighting of 2.53% among all his current holdings.

Latest Holdings of Mark W Perry

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
FNIO	iShares Indl/Office Real Estate Capped	2012-03-01	16,578,379	31.89	528,684,506
ECHO	Echo Global Logistics Inc	2009-10-01	2,420,219	48.24	116,751,365
FOLD	Amicus Therapeutics Inc	2012-03-07	5,650,340	9.11	51,474,597
INWK	InnerWorkings Inc	2012-02-29	6,029,190	2.99	18,027,278
CBIO	Catalyst Biosciences Inc	2006-04-12	3,343	7.67	25,639
NOVCQ	Novation Companies Inc	2006-05-15	1,225,179	0.00	123
TIVO	TiVo Corp	2009-06-03	0	6.09	0

Holding Weightings of Mark W Perry

Mark W Perry Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark W Perry has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 1,564 shares on March 1, 2012, which brought Mark W Perry around $46,920.

According to the SEC Form 4 filings, Mark W Perry has made a total of 0 transactions in Echo Global Logistics Inc (ECHO) over the past 5 years. The most-recent trade in Echo Global Logistics Inc is the sale of 0 shares on October 1, 2009, which brought Mark W Perry around $0.

According to the SEC Form 4 filings, Mark W Perry has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the acquisition of 1,140,000 shares on March 7, 2012, which cost Mark W Perry around $6 Million.

More details on Mark W Perry's insider transactions can be found in the Insider Trading History of Mark W Perry table.

Insider Trading History of Mark W Perry

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark W Perry Trading Performance

GuruFocus tracks the stock performance after each of Mark W Perry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark W Perry is -15%. GuruFocus also compares Mark W Perry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark W Perry within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark W Perry's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark W Perry

Average Return

Average return per transaction

Outperforming Transactions

1 out of 3 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-9.97
Relative Return to S&P 500(%)	-10.18

Mark W Perry Ownership Network

Ownership Network List of Mark W Perry

No Data

Ownership Network Relation of Mark W Perry

Mark W Perry Owned Company Details

What does Workday Inc do?

Who are the key executives at Workday Inc?

Mark W Perry is the 10 percent owner of Workday Inc. Other key executives at Workday Inc include Co-President Sayan Chakraborty , 10 percent owner David A Duffield , and EVP & General Counsel & Secty Richard Harry Sauer .

Workday Inc (WDAY) Insider Trades Summary

Over the past 18 months, Mark W Perry made no insider transaction in Workday Inc (WDAY). Other recent insider transactions involving Workday Inc (WDAY) include a net sale of 2,726,529 shares made by David A Duffield , a net sale of 57,016 shares made by Richard Harry Sauer , and a net sale of 50,165 shares made by Sayan Chakraborty .

In summary, during the past 3 months, insiders sold 508,642 shares of Workday Inc (WDAY) in total and bought 0 shares, with a net sale of 508,642 shares. During the past 18 months, 2,923,897 shares of Workday Inc (WDAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,923,897 shares.

Workday Inc (WDAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Workday Inc Insider Transactions

No Available Data

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Mark W Perry is the 10 percent owner of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include SVP & Chief Medical Officer Jonathan Rubin , Sr. VP of IP & CSO Padmanabh P. Bhatt , and director & President & CEO Jack A. Khattar .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Mark W Perry made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 132,750 shares made by Padmanabh P. Bhatt , a net sale of 38,886 shares made by Georges Gemayel , and a net sale of 250,000 shares made by Jack A. Khattar .

In summary, during the past 3 months, insiders sold 13,677 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 13,677 shares. During the past 18 months, 477,688 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 477,688 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

What does InnerWorkings Inc do?

Who are the key executives at InnerWorkings Inc?

Mark W Perry is the 10 percent owner of InnerWorkings Inc. Other key executives at InnerWorkings Inc include director & President and CEO Richard S Stoddart , Chief Accounting Officer John Bosshart , and Executive VP and CFO Donald W Pearson .

InnerWorkings Inc (INWK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of InnerWorkings Inc (INWK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InnerWorkings Inc (INWK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

InnerWorkings Inc (INWK)'s detailed insider trading history can be found in Insider Trading Tracker table.

InnerWorkings Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Mark W Perry is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Mark W Perry made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 162,569 shares made by Bradley L Campbell , a net sale of 284,883 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 400 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 400 shares. During the past 18 months, 648,327 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 648,327 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

What does Echo Global Logistics Inc do?

Who are the key executives at Echo Global Logistics Inc?

Mark W Perry is the 10 percent owner of Echo Global Logistics Inc. Other key executives at Echo Global Logistics Inc include director & Chief Executive Officer Douglas R Waggoner , Chief Financial Officer David B Menzel , and Controller Douglas Hong .

Echo Global Logistics Inc (ECHO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Echo Global Logistics Inc (ECHO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Echo Global Logistics Inc (ECHO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Echo Global Logistics Inc (ECHO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Echo Global Logistics Inc Insider Transactions

No Available Data

What does Groupon Inc do?

Who are the key executives at Groupon Inc?

Mark W Perry is the 10 percent owner of Groupon Inc. Other key executives at Groupon Inc include other: See Footnote 1 and Remarks Dusan Senkypl , Interim CAO Kyle Netzly , and Chief Financial Officer Jiri Ponrt .

Groupon Inc (GRPN) Insider Trades Summary

Over the past 18 months, Mark W Perry made no insider transaction in Groupon Inc (GRPN). Other recent insider transactions involving Groupon Inc (GRPN) include a net purchase of 323,344 shares made by Dusan Senkypl , a net purchase of 15,000 shares made by Jason Harinstein , and a net sale of 4,583 shares made by Robert J Bass .

In summary, during the past 3 months, insiders sold 0 shares of Groupon Inc (GRPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,583 shares of Groupon Inc (GRPN) were sold and 338,344 shares were bought by its insiders, resulting in a net purchase of 333,761 shares.

Groupon Inc (GRPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Groupon Inc Insider Transactions

No Available Data

What does Glu Mobile Inc do?

Who are the key executives at Glu Mobile Inc?

Mark W Perry is the 10 percent owner of Glu Mobile Inc. Other key executives at Glu Mobile Inc include EVP & COO and CFO Eric R Ludwig , Senior Vice President & Revenue Becky Ann Hughes , and SVP & Business & Corp. Dev. Chris Akhavan .

Glu Mobile Inc (GLUU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Glu Mobile Inc (GLUU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Glu Mobile Inc (GLUU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Glu Mobile Inc (GLUU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Glu Mobile Inc Insider Transactions

No Available Data

What does Boingo Wireless Inc do?

Who are the key executives at Boingo Wireless Inc?

Mark W Perry is the 10 percent owner of Boingo Wireless Inc. Other key executives at Boingo Wireless Inc include Chief Technology Officer Derek Peterson , Chief Financial Officer Peter Hovenier , and Chief Marketing Officer Dawn Callahan .

Boingo Wireless Inc (WIFI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Boingo Wireless Inc (WIFI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Boingo Wireless Inc (WIFI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Boingo Wireless Inc (WIFI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Boingo Wireless Inc Insider Transactions

No Available Data

What does Vonage Holdings Corp do?

Who are the key executives at Vonage Holdings Corp?

Mark W Perry is the 10 percent owner of Vonage Holdings Corp. Other key executives at Vonage Holdings Corp include SVP Corporate Development Vinod Lala , Interim Chief Legal Officer Randy K. Rutherford , and director & Chief Executive Officer Rory P Read .

Vonage Holdings Corp (VG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vonage Holdings Corp (VG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vonage Holdings Corp (VG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vonage Holdings Corp (VG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vonage Holdings Corp Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

Mark W Perry is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Newhall Charles W Iii .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does Financial Engines Inc do?

Who are the key executives at Financial Engines Inc?

Mark W Perry is the 10 percent owner of Financial Engines Inc. Other key executives at Financial Engines Inc include EVP & COO & Pres FE Advisors John Bunch , EVP & CFO Craig L Foster , and other: See footnotes (1)(2)(3)(4) Warburg Pincus Llc .

Financial Engines Inc (FNGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Financial Engines Inc (FNGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Financial Engines Inc (FNGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Financial Engines Inc (FNGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Financial Engines Inc Insider Transactions

No Available Data

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Mark W Perry is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Voltari Corp do?

Who are the key executives at Voltari Corp?

Mark W Perry is the 10 percent owner of Voltari Corp. Other key executives at Voltari Corp include 10 percent owner Carl C Icahn , Chief Financial Officer Nathan Yu-gai Fong , and SVP & Gen Counsel & Corp Sec Richard Jr Leigh .

Voltari Corp (VLTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Voltari Corp (VLTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Voltari Corp (VLTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Voltari Corp (VLTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Voltari Corp Insider Transactions

No Available Data

What does W World Corp do?

Who are the key executives at W World Corp?

Mark W Perry is the 10 percent owner of W World Corp. Other key executives at W World Corp include director & 10 percent owner Anthony B Evnin , director & 10 percent owner Newhall Charles W Iii , and President and CFO Neill Sydney Colin .

W World Corp (WWHC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of W World Corp (WWHC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of W World Corp (WWHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

W World Corp (WWHC)'s detailed insider trading history can be found in Insider Trading Tracker table.

W World Corp Insider Transactions

No Available Data

What does Inteliquent Inc do?

Who are the key executives at Inteliquent Inc?

Mark W Perry is the 10 percent owner of Inteliquent Inc. Other key executives at Inteliquent Inc include director & President and CEO Matthew Jr Carter , Chief Financial Officer / EVP Kurt Abkemeier , and 10 percent owner C Richard Kramlich .

Inteliquent Inc (IQNT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Inteliquent Inc (IQNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inteliquent Inc (IQNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Inteliquent Inc (IQNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inteliquent Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Mark W Perry is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does DZS Inc do?

Who are the key executives at DZS Inc?

Mark W Perry is the 10 percent owner of DZS Inc. Other key executives at DZS Inc include director & President & CEO Charles D Vogt , Chief Customer Officer & AEMEA Gunter Reiss , and Chief Financial Officer Misty Dawn Kawecki .

DZS Inc (DZSI) Insider Trades Summary

Over the past 18 months, Mark W Perry made no insider transaction in DZS Inc (DZSI). Other recent insider transactions involving DZS Inc (DZSI) include a net purchase of 10,000 shares made by Matthew W Bross , and a net purchase of 10,000 shares made by Charles D Vogt .

In summary, during the past 3 months, insiders sold 0 shares of DZS Inc (DZSI) in total and bought 19,000 shares, with a net purchase of 19,000 shares. During the past 18 months, 0 shares of DZS Inc (DZSI) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 20,000 shares.

DZS Inc (DZSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

DZS Inc Insider Transactions

No Available Data

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Mark W Perry is the 10 percent owner of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Catalyst Biosciences Inc Insider Transactions

No Available Data

What does Aradigm Corp do?

Who are the key executives at Aradigm Corp?

Mark W Perry is the 10 percent owner of Aradigm Corp. Other key executives at Aradigm Corp include 10 percent owner Bleichroeder Lp , 10 percent owner First Eagle Investment Management, Llc , and 10 percent owner 21 April Fund Lp .

Aradigm Corp (ARDMQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aradigm Corp (ARDMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aradigm Corp (ARDMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aradigm Corp (ARDMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aradigm Corp Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Mark W Perry is the 10 percent owner of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, Mark W Perry made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 7,125 shares made by Daniel R. Chevallard , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,125 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 92,875 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

Mark W Perry Mailing Address

Above is the net worth, insider trading, and ownership report for Mark W Perry. Currently GuruFocus does not have mailing address information for Mark W Perry.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.